California State Teachers Retirement System (CalSTRS)’s Faeth Therapeutics FTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-455
Closed -$21K 3286
2022
Q1
$21K Sell
455
-110
-19% -$8.75K ﹤0.01% 3166
2021
Q4
$65K Hold
565
﹤0.01% 3109
2021
Q3
$119K Buy
565
+39
+7% +$7.1K ﹤0.01% 2939
2021
Q2
$103K Sell
526
-49
-9% -$12.1K ﹤0.01% 3041
2021
Q1
$167K Buy
+575
New +$192K ﹤0.01% 2961

Other funds holding FTH

California State Teachers Retirement System (CalSTRS)'s FTH Position: Q2 2022 in Review

California State Teachers Retirement System (CalSTRS) sold out of Faeth Therapeutics (FTH) in Q2 2022, closing a stake of 455 shares — an estimated $21K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in FTH in Q1 2021 and held it in 5 quarters. The position peaked at $167K in Q1 2021. 39 funds tracked by Wall St. Rank hold FTH as of Q2 2022.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Faeth Therapeutics position as of Q2 2022 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 455 Faeth Therapeutics shares in Q2 2022, an estimated $21K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Faeth Therapeutics in Q1 2021 and held it in 5 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Faeth Therapeutics position peaked at $167K in Q1 2021.
  • 39 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q2 2022.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2022, filed 15 Aug 2022.